William Pridgen, Director at Virios Therapeutics, Inc. (VIRI), bought 1,500 shares at $11.98 ($18K) on 2020-12-17, disclosed to the SEC on 2020-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| VIRI | BUY | 2022-05-18 | $59K | — | Filing → |
| VIRI | BUY | 2022-03-30 | $3K | — | Filing → |
| VIRI | BUY | 2022-03-24 | $12K | — | Filing → |